NCT06387342 2025-01-31Namodenoson Treatment of Advanced Pancreatic CancerCan-Fite BioPharmaPhase 2 Recruiting20 enrolled
NCT00790218 2022-05-17A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular CarcinomaCan-Fite BioPharmaPhase 1/2 Completed19 enrolled 6 charts